In a challenging year for Adagio Therapeutics (NASDAQ:IVVD), the biotech company's stock has tumbled to a 52-week low, reaching a price level of just $0.38. This latest dip underscores a prolonged ...
Boat and marine products retailer OneWater Marine (NASDAQ:ONEW) in Q4 CY2024, with sales up 3.2% year on year to $375.8 ...
Blackwell production has ramped up to 100%; there are plans for capacity expansion, including into the U.S., and the next-gen technology will soon be available. Rubin, the next iteration of NVIDIA’s ...
Inc. has been notified by the Nasdaq Stock Market of a potential delisting due to its Market Value of Listed Securities falling below the required minimum. The laboratory analytical instruments ...
It reported sales of $48.4 billion and earnings of $8.02 per share, compared to the consensus estimates of $47.0 billion and ...
As the first earnings cycle of 2025 is ramping up, so are the announcements of new share buyback authorizations. Among these announcements, three big-name U.S. stocks stick out so far, all of which ...
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ:GCTK), a medical device company specializing in diabetes care technology, has ...